Atlas Trials

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms

Clinical trial NCT07073053 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07073053
Sponsor
Taipei Veterans General Hospital, Taiwan
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Glucagon-Like Peptide-1 Receptor AgonistsType 2 DiabetesCoronary Arterial Disease (CAD)
Start date
2025-10-01
Primary completion
2028-07-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.